Safety of a Noninvasive Expandable Electromagnetic Prosthesis with an In Situ Ventricular Assist Device: A Case Report

Nicholas P. Gannon, Kristy M. McHugh, Rebecca K. Ameduri, Christian M. Ogilvie

Research output: Contribution to journalArticlepeer-review

Abstract

CASE: An 8-year-old girl was diagnosed with osteosarcoma of the distal femur. She underwent chemotherapy and wide resection with implantation of a noninvasive electromagnetic expandable distal femur prosthesis. Ninety-three days after chemotherapy, she developed anthracycline-induced cardiomyopathy with heart failure for which a ventricular assist device was placed. Device compatibility was tested, and she was successfully lengthened. CONCLUSION: Expandable prostheses allow limb length maintenance in skeletally immature patients who undergo limb salvage. Chemotherapy for osteosarcoma involves anthracyclines with a dose-dependent side effect of cardiotoxicity. Patients can be successfully and safely lengthened with expandable electromagnetic prostheses with in situ ventricular assist devices.

Original languageEnglish (US)
JournalJBJS case connector
Volume11
Issue number2
DOIs
StatePublished - Apr 27 2021

Bibliographical note

Publisher Copyright:
Copyright © 2021 by The Journal of Bone and Joint Surgery, Incorporated.

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'Safety of a Noninvasive Expandable Electromagnetic Prosthesis with an In Situ Ventricular Assist Device: A Case Report'. Together they form a unique fingerprint.

Cite this